NovaBridge Biosciences NBP
NASDAQ NBP
$1.36 -0.01 (-0.73%)
As of: Sep 30, 2026 · 9:57 AM EDT

NovaBridge Biosciences (NBP) EBIT Margin (2019 - 2023)

Updated

NovaBridge Biosciences (NBP) reported EBIT Margin of -789260.00% for Q4 2023, down 785884.13 percentage points from the prior quarter.

Analysis

NovaBridge Biosciences (NBP) EBIT Margin (2019 - 2023) Analysis & Trends

For FY2023, NovaBridge Biosciences posted EBIT Margin of -31313.96%, down 12401.77 percentage points from FY2022.

  • EBIT Margin has declined for three consecutive years, with a five-year change of -30498.35 percentage points (FY2018 to FY2023).
  • By year, EBIT Margin came in at -18912.18% in FY2022 (-16587.40 pp), -2324.79% in FY2021 (-2319.51 pp), -5.27% in FY2020 (+4878.23 pp) and -4883.50% in FY2019 (-4067.90 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 NovaBridge Biosciences 149.78 Mn 149.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -789,260.00%
Sep 30, 2023 -3,375.87%
Jun 30, 2023 -7,578.62%
Dec 31, 2020 60.24%
Sep 30, 2019 -2,042.94%
API Access

NovaBridge Biosciences EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=NBP&period=max&api_key=YOUR_API_KEY